NCT03610945 - Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

August 15, 2018

Study Completion Date

August 21, 2018

Conditions

NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG

Fluconazole

Subjects will receive fluconazole once daily from Day 5 to Day 18

DRUG

Quinidine

Subjects will receive quinidine twice daily from Day 5 to Day 12

DRUG

EDP-305

Subjects will receive a single dose of EDP-305 on Day 1 and Day 14

DRUG

EDP-305

Subjects will receive a single dose of EDP-305 on Day 1 and Day 8

Trial Locations (1)

Pharmaceutical Research Associates, Inc.,, Salt Lake City